OR5BH1P

Across TCGA pan-cancer cohorts, OR5BH1P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of OR5BH1P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where OR5BH1P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR5BH1P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

HNSC, LUSC, and COAD are the cancer types where OR5BH1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR5BH1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.096	<.001	8	view →
LUSC	All	II,III,IV	+0.501	<.001	6	view →
COAD	All	All	+0.023	.029	2	view →
LIHC	All	II,III,IV	+0.014	.044	2	view →
THCA	All	IV	−0.095	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

OR5BH1P–HNSC

Open the HNSC breakdown →